Evidence-based guidelines serve as cost-effective resources to standardize the care of diabetes patients. Ample evidence exists to instruct physicians on improving the quality of life of diabetes patients by providing optimal diabetes care.
Treatment targets for dyslipidemia have been developed by several national and international organizations (ADA, AACE, AADE, NCEP/ATP III, and IDF/WHO).